
Sitagliptin (50mg) + Metformin (1000mg)
Active composition
+1 more active ingredient
Sitagliptin inhibits DPP-4, increasing incretin levels, which stimulate insulin release and reduce glucagon secretion.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Emsita M 50mg/1000mg Tablet is a combination medication containing Sitagliptin and Metformin that helps control blood glucose levels. Sitagliptin enhances the action of incretin hormones, which help increase insulin release and reduce glucose production after meals. Metformin works by decreasing glucose production in the liver and improving insulin sensitivity in the body. The combined action of these medicines helps maintain stable blood sugar levels and improve glycemic control. Proper management of blood glucose is important for reducing the risk of long term complications associated with diabetes. The medicine is usually taken according to the dosage prescribed by a healthcare professional. Lifestyle measures such as balanced diet and regular exercise may further support treatment effectiveness. When used consistently under medical supervision, Emsita M 50mg/1000mg Tablet helps support effective diabetes management and overall metabolic health.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Emsita M 50mg/1000mg Tablet during pregnancy is not available. Please consult your doctor.
High Risk
Emsita M 50mg/1000mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Emsita M 50mg/1000mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Emsita M 50mg/1000mg Tablet may be needed. Please consult your doctor. Use of Emsita M 50mg/1000mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Emsita M 50mg/1000mg Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
0 reviews for Emsita M 50mg/1000mg Tablet

Sitagliptin (50mg) + Metformin (1000mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Sitagliptin inhibits DPP-4, increasing incretin levels, which stimulate insulin release and reduce glucagon secretion.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Emsita M 50mg/1000mg Tablet is a combination medication containing Sitagliptin and Metformin that helps control blood glucose levels. Sitagliptin enhances the action of incretin hormones, which help increase insulin release and reduce glucose production after meals. Metformin works by decreasing glucose production in the liver and improving insulin sensitivity in the body. The combined action of these medicines helps maintain stable blood sugar levels and improve glycemic control. Proper management of blood glucose is important for reducing the risk of long term complications associated with diabetes. The medicine is usually taken according to the dosage prescribed by a healthcare professional. Lifestyle measures such as balanced diet and regular exercise may further support treatment effectiveness. When used consistently under medical supervision, Emsita M 50mg/1000mg Tablet helps support effective diabetes management and overall metabolic health.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Emsita M 50mg/1000mg Tablet during pregnancy is not available. Please consult your doctor.
High Risk
Emsita M 50mg/1000mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Emsita M 50mg/1000mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Emsita M 50mg/1000mg Tablet may be needed. Please consult your doctor. Use of Emsita M 50mg/1000mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Emsita M 50mg/1000mg Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
0 reviews for Emsita M 50mg/1000mg Tablet













